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Summary
a 67-year-old man presented to ear, nose and throat 
department complaining of nasal congestion and 
recurrent epistaxis for 5 months. Nasal endoscopy 
revealed a pigmented polyp obstructing the right nasal 
cavity. MrI with contrast agent showed a right nasal 
cavity polypoid mass with hyper signal intensity (sI) 
both in non-enhanced t1-w and diffusion imaging, 
marked hypo sI in t2-w sequences and avidly contrast 
enhancement characterised by rapid wash-in without 
significant wash-out on dynamic perfusion imaging. 
Histological specimen showed epithelioid and 
spindle cells with focal intense pigmentations and 
immunohistochemical features compatible with primary 
melanotic sinonasal mucosal melanoma (sNM). as 
melanotic sNM shows MrI pathognomonic high non-
enhanced t1-w sI, this case underlines the crucial role 
of MrI not only in assessing the local tumour extension/
recurrence but also in increasing the diagnostic 
confidence of detecting melanotic sNM. thus, MrI should 
be always performed in case of clinical–endoscopic 
suspicion of sNM.
BaCkground
Primary malignant sinonasal mucosal melanoma 
(SNM) is a rare and heavily aggressive sinonasal 
neoplasm. It represents <4% of all head and neck 
cancer, 55% of all head and neck melanoma and 
0.3%–2% of all melanomas (annual incidence rate 
0.5 per million).1 SNM mostly arises from mela-
nocytes of the mucosa of the nasal cavity (50% of 
cases) and paranasal sinuses (20%).2–4 The average 
age of onset for SNM is 65 years (M:F 3:2).5 The 
etiopathogenetic is related to the cigarette smoking, 
formaldehyde and genetic alterations, whereas the 
solar exposure does not seem to play a key role.4 
The primary sites of involvement are the nasal 
septum, the nasal lateral wall and the inferior nasal 
concha.1 It is necessary to exclude that the tumour 
is the secondary manifestation of cutaneous or 
uveal melanomas.2 Furthermore, symptoms are no 
specific (epistaxis, nasal obstruction and headache) 
and therefore the diagnosis is often delayed.6 MRI 
with contrast agent is the technique of choice in the 
study of monolateral sinonasal polypoid lesion since 
it distinguishes between solid lesions and inflam-
matory mucosal changes. As melanin has strongly 
hyperintense and hypointense signal intensity (SI) 
respect to the muscle in non-enhanced T1-w and 
T2-w sequences, respectively,3 MRI can be an 
important diagnostic tool in the diagnosis of mela-
notic SNM. MRI with diffusion-weighted imaging 
(DwI) and dynamic contrast enhancement imaging 
(DCE-PwI) can provide useful functional informa-
tion in the characterisation of SNM. Moreover, 
MRI plays a basic role in the local–regional staging 
of malignant neoplasms with a higher diagnostic 
Figure 1 T1-w non-contrast enhanced coronal 
MRI. Polypoid lesion in the right nasal cavity with 
heterogeneous hyper signal intensity involves the inferior 
and middle meatus.
Figure 2 Apparent diffusion coefficient (ADC) map 
shows a polypoid lesion in the right nasal cavity with 
low ADC values, a typical feature of SNM. Bilateral 
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accuracy than CT in the assessment of dural, anterior skull base 
and orbit invasion.7 8 
CaSe preSenTaTion
A 67-year-old patient presented to ear, nose and throat depart-
ment complaining of nasal congestion and recurrent epistaxis 
for 5 months. Anticoagulant therapy, previous head and neck 
surgery, and history of tumour were not referred in anamnesis. 
The clinical examination showed a nasal profile deformation.
inveSTigaTionS
Baseline biochemical and haematological investigations showed 
no abnormalities. The nasal endoscopy revealed a pigmented, 
ulcerated and friable polypoid mass that completely obstructed 
the right nasal cavity. MRI showed a mass occupying the right 
middle and inferior meatus characterised by hyper SI both in 
T1-w (figure 1) and DwI sequences (figure 2), and marked hypo 
SI in T2-w sequences. After intravenous contrast agent injection, 
the lesion showed marked enhancement with rapid wash-in and 
without significant wash-out on DCE-PwI time/intensity curve 
(figure 3). Therefore, an endoscopic biopsy was performed. 
Histological specimen of the lesion showed epithelioid and 
spindle cells with a focal and intense melanin pigmentation and 
immunohistochemical features compatible with primary sinon-
asal melanotic mucosal melanoma (figures 4 and 5).
TreaTmenT
The patient underwent the surgical removal of the nasal mass 
and subsequent cycles of radiotherapy and chemotherapy.
ouTCome and Follow-up
In the staging phase, fluorodeoxyglucose (18F-FDG) positron emis-
sion tomography (PET) and total body CT with contrast agent 
showed a pancreatic metastasis (figure 6). Early follow-up with 
Figure 3 Dynamic contrast enhancement perfusion-weighted imaging 
time–intensity curve shows a rapid wash-in without significant wash-
out, a finding highly suspicious for malignancy.
Figure 4 Histological specimen shows an aggregate of epithelioid and 
spindle cells with focal and intense pigmentation (magnification, 5x).
Figure 5 Positivity for Melanoma-associated antigen recognized by T 
cells (MART-1) immunostaining (magnification, 20x).
Figure 6 18F-FDG positron emission tomography detects significant 
accumulation of the tracer in the nasal cavity (black arrow) and 
pancreatic head (black dotted arrow).
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total body CT showed both local and distant relapses of the disease. 
Metastases in the right temporal muscle (figure 7), bladder dome 
and lung appeared. Therefore, the immunological therapy was 
implemented. Nevertheless, the next CT scan revealed a further 
rapid progression of the disease with an increase of lung nodules and 
the appearance of liver metastases. The patient died after 3 months.
diSCuSSion
MRI plays a crucial role in the diagnosis, characterisation and 
local–regional staging of SNM. Therefore, MRI should be 
always performed if SNM is suspected from clinical–endoscopic 
examination. MRI features of SNM are variable, due to varying 
amounts of melanin, with up to one-third of cases being amela-
notic.9 Melanin has strongly hyperintense SI respect to the muscle 
in non-enhanced T1-w and hypointense SI in T2-w sequences,3 
thus melanotic SNM can be easily detected with MRI. On the 
contrary, amelanotic melanoma appears isointense to muscle in 
non-enhanced T1-w sequences.6 In SNM, DwI shows diffusion 
restriction with a high signal in images at high b-value (b800–
1000) and low values in apparent diffusion coefficient (ADC) 
map, that prove the typical behaviour of malignant lesions 
(figure 2).10 DCE-PwI examines microvascular characteristics of 
tumour tissue giving information about benignity or malignancy. 
Malignant tumours are expected to have a rapid and vividly 
enhancement, despite benign lesions tend to have a progressive 
enhancing pattern.11 12 Tumour invasion of the orbits, base of the 
skull, intracranial and nasopharynx is common. T2-w sequences 
on the coronal plane allow to evaluate the erosion of the orbit 
inferior wall, lamina papyracea and ethmoidal cribriform plate, 
whereas isotropic–isovolumetric fat saturation sequences with 
contrast enhanced help to identify the infiltration of the dura 
mater and/or anterior cranial fossa.7 8 13 Cerebral oedema and 
leptomeningeal/cerebral impregnation in direct contact with the 
tumour are indicative of brain involvement.14 Distant metas-
tases are common too.15 18F-FDG PET-CT scan FDG-PET/CT 
has been shown to be useful in evaluating residual or recurrent 
SNM.16 SNM is a very aggressive tumour with a poor prognosis 
with up to 64% recurrence 1 year after surgery17 and overall 
5-year survival <25%.18 In conclusion, SNM is a rare entity 
and the nasal cavity is the most common site of origin. MRI can 
provide significant information in the diagnosis and local staging 
of SNM. High MRI SI on non-contrast enhanced T1-w and DwI 
sequences, low ADC values and rapid wash-in without note-
worthy wash-out on DCE-PwI are very suggestive of melanotic 
SNM. PET-CT examination is mandatory for the assessment of 
distant metastasis.
learning points
 ► MRI with contrast agent is the technique of choice in 
the study of monolateral sinonasal polypoid lesion since 
it distinguishes between solid lesions and inflammatory 
mucosal changes.
 ► MRI plays a crucial role in the diagnosis and local–regional 
staging of sinonasal mucosal melanoma (SNM) and, 
therefore, it should be always performed in case of clinical–
endoscopic suspicion.
 ► Melanoma of the head and neck region is a rare entity and 
the nasal cavity is its most common site of origin. Melanotic 
SNM shows pathognomonic MRI features, especially a high 
signal intensity (SI) on non-contrast enhanced T1-w and 
diffusion-weighted imaging sequences, low SI on T2-w, 
and marked enhancement after intravenous contrast agent 
injection.
 ► 18F-FDG positron emission tomography-CT examination 
is mandatory in patients with SNM both for diagnosis 
and follow-up to screen for distal metastases and local 
recurrences since they are common events and often 
associated with poor prognosis.
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